|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Polycationic proteins, e.g., major basic protein from eosinophils or cathepsin G from neutrophils, have been shown to increase nonspecific airway responsiveness. Along with several
indirect manners of action, polycations were reported to contract smooth-muscle strips and to raise the cellular Ca2+ concentration as a direct action on airway smooth muscle. However, the mechanistic basis for the direct behavior remains to
be elucidated. To address this issue, we examined the effects
of synthetic cationic polypeptides poly-L-arginine and poly-L-lysine on fresh single smooth-muscle cells from bovine trachea using a patch-clamp technique. Both of the polycations
significantly depolarized the membrane from a baseline of
about
40 to
20 mV in a dose-dependent manner. The polycations also suppressed whole-cell spontaneous transient outward currents as well as both the conductance (from a baseline of about 130 to 70 pS) and open-state probability (about
25% of control values) of large-conductance Ca2+-dependent
K+ channel (maxi-K channel) on excised outside-out patch
membranes. The polycations were without effect on the whole-cell Ca2+ currents induced by depolarizing voltage pulses. We
concluded that the synthetic polycations had at least two sites
of action; one is the delayed rectifier K+ channel that is responsible for the membrane depolarization that increases
Ca2+ influx, and the other is the maxi-K channel the suppression of which inhibits muscle relaxation. These results may explain the direct contractile action and, therefore, one of the
mechanisms underlying the airway hyperresponsiveness induced by various polycationic proteins.
| |
Introduction |
|---|
|
|
|---|
Nonspecific airway hyperresponsiveness (AHR) to inhaled stimuli such as histamine and methacholine is an important diagnostic feature of bronchial asthma (1). Bronchial asthma has been characterized as chronic airway inflammation associated with airway infiltration of various inflammatory cells, including eosinophils (2). Activated eosinophils are known to secrete cationic proteins, such as major basic protein (MBP) (3), that have been suggested to be involved in AHR in various ways (4). MBP is a highly cationic polypeptide (3) and the effect of MBP is mimicked by synthetic polycations, such as poly-L-arginine (pL-Arg) and poly-L-lysine (pL-Lys) (4, 6).
Chronic bronchitis is a clinical entity characterized by
cough and mucus hypersecretion and is sometimes referred
to as neutrophilic bronchitis, whereas bronchial asthma
may be thought of as eosinophilic bronchitis. These different entities share some common features, especially AHR
(9). Tracheal instillation of cathepsin G, one of the cationic proteins from neutrophils, has been reported to induce AHR without producing epithelial damage in rat in
vivo (10). Neutrophils have also been shown to inhibit the
arachidonate-induced relaxation of guinea-pig trachea, as
do eosinophils (11). Moreover, a population-based study
suggested that the leukocyte count, particularly that of
neutrophils, paralleled the bronchial methacholine responsivity (12). In addition to MBP from eosinophils and
cathepsin G from neutrophils, a number of cationic proteins have been identified in a variety of cell types, e.g.,
neutrophils (
-defensins, cationic antimicrobial protein
[CAP] 37, and CAP 57/BPI/BP) (13), platelet (platelet factor [PF] 4) (14), and airway epithelial cells (
-defensins) (15). These cationic proteins have principally been considered in the context of defense mechanisms against bacterial and parasitic invasion, probably by alterating the membrane permeability, which ultimately leads to cell death
(16). In addition to the antimicrobial action, these cationic
proteins may play roles in the pathogenesis of AHR in
chronic inflammatory airway diseases, including bronchial asthma and chronic bronchitis.
Although the cationic charge appears to be important in many of the biologic actions of cationic proteins (10, 17), the precise mechanism and site of action underlying their ability to increase airway responsiveness are unknown. MBP has been reported to augment agonist-elicited smooth-muscle contraction indirectly in an epithelial-dependent manner in guinea pig in vitro (5). In addition, MBP and synthetic polycations induced AHR in vivo with mechanisms mediated by the generation of bradykinin (6) or by stimulating the parasympathetic nervous system (7) in guinea pig. As well as these indirect mechanisms, synthetic polycations including pL-Arg and pL-Lys have been reported to contract isolated guinea-pig trachea directly in a concentration-dependent, epithelial-independent manner (8). In a recent investigation, this direct contractile action of synthetic polycations and MBP was also shown in bovine tracheal smooth-muscle strips (4). Moreover, the investigators found, using fura-2 Ca2+-indicator dye, that the cationic proteins increased the cellular Ca2+ concentration ([Ca2+]i) and augmented the histamine- or bradykinin-stimulated [Ca2+]i responses in cultured bovine tracheal smooth-muscle cells (4). These findings may explain the mechanism of the direct contractile action of polycations on airway smooth muscle that results in hyperresponsiveness. However, the mechanistic basis for the polycation-induced Ca2+ mobilization in airway smooth muscle still remained to be elucidated. To address this issue, we examined the effects of synthetic cationic polypeptides pL-Arg and pL-Lys on single smooth-muscle cells from bovine trachea using a patch-clamp technique. Here we demonstrate that the model polycations depolarized the tracheal smooth-muscle membrane and inhibited large-conductance Ca2+-dependent K+ channels (maxi-K channels) without affecting the Ca2+-influx pathway (L-type Ca2+ channels). The depolarization may activate the voltage-dependent Ca2+ channels on the plasma membrane, resulting in an increased Ca2+ influx from extracellular compartments, which will ultimately energize the intracellular contractile machinery. The suppression of maxi-K channels may further intensify the contractile effect by inhibiting the relaxation of airway smooth muscle.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Preparation
Fresh bovine tracheae were obtained from a local abattoir and immediately transferred into an ice-cold transportation solution containing (in mM) 140 NaCl, 4.7 KCl, 1.13 MgCl2, 10 glucose, and 10 N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes). The smooth-muscle layer was isolated from the posterior membranous portion of the trachea, the surrounding connective tissue and epithelium were removed, and the isolated smooth-muscle strips were cut into small pieces. These smooth-muscle strips were then dispersed enzymatically into single cells with collagenase (100 U/ml), papain (1 mg/ml), and DL-dithiothreitol (2 mM) for 40 min at 37°C. After incubation, the tissue pieces were gently agitated and single smooth-muscle cells were resuspended in the extracellular solution.
Electrical Recordings
Standard patch-clamp recording techniques were used. Ionic currents were measured with a patch-clamp amplifier (EPC9; HEKA Electronic, Lambrecht/Pfalz, Germany), low-pass filtered at 1 kHz
and monitored on both a built-in software oscilloscope and a thermal pen recorder (RECTI-HORIZ-8K; Nippondenki Sanei, Tokyo, Japan) with a bandwidth of 0 to 300 Hz. Patch pipettes were
made of glass capillary (Drummond Scientific Co., Broonall, PA)
with an outer diameter of 1.5 mm using a vertical puller (PP-83;
Narishige Scientific Instruments, Tokyo, Japan), and had a tip
resistance of 4 to 6 M
. The junction potential between the
patch-pipette and bath solution was nulled by the amplifier circuitry. After establishing a high-resistance (> 2 G
) tight seal,
the whole-cell configuration was obtained by rupturing the patch
membrane with negative pressure applied to the pipette tip. The
estimated leakage currents were subtracted on the basis of the responses to depolarizing or hyperpolarizing pulses, and the capacitance current and series resistance were compensated using the
amplifier circuitry. The outside-out patch was obtained after the
establishment of the whole-cell configuration by raising the patch
electrode to the air-water interface. In the excised patch experiments, channel signals were low-pass filtered at 30 kHz, stored by
a digital-audio tape recorder (TEAC RD-125T; TEAC, Tokyo,
Japan), and then analyzed with Patch Analyst Pro software (TM
Corp., Tokyo, Japan). In analyzing the open-state probabilities
(nPos) and unitary current amplitudes, current signals stored in
the digital audiotape were digitized at 4 kHz and low-pass filtered
at 1.0 kHz. When reproducing the channel currents as a figure,
we used a digital thermal recorder (Thermal Arraycorder WR7700;
Graphtec, Tokyo, Japan) with a bandwidth of 5 kHz, directly connected to the digital audiotape recorder. The solutions used were
of the following composition (in mM): extracellular (bath) solution, 140 NaCl, 4.7 KCl, 1.13 MgCl2, 1.2 CaCl2, 10 glucose, and 10 Hepes; and intracellular (pipette) solution, 140 KCl, 1.13 MgCl2,
10 Hepes, 10 glucose, 0.5 ethyl glycol-bis(
-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA), and 1 Na2-adenosine triphosphate (ATP), adjusted to pH 7.2 with NaOH (bath solution) or
KOH (pipette solution). In the experiments isolating the delayed-rectifier K+ current, the solutions used were of the following
composition (in mM): the extracellular, 110 tetraethyl ammonium
(TEA)-Cl, 1.13 MgCl2, 10 Hepes, 10 glucose, and 1.2 CaCl2; and
the intracellular, 140 KCl, 1.13 MgCl2, 10 Hepes, 10 EGTA, 10 glucose, and 1 Na2ATP. In the experiments measuring the inward
Ca2+ current, the solutions used were (in mM): the extracellular, 110 TEA-Cl, 1.13 MgCl2, 10 Hepes, 10 glucose, and 20 CaCl2; and the intracellular, 130 CsCl2, 1.13 MgCl2, 10 Hepes, 0.5 EGTA, and 10 glucose; and the pH was adjusted to 7.2 by Tris [hydroxymethyl] aminomethane. All experiments were carried out at room
temperature, 20 to 25°C. The fluids were superfused over the cell
by hydrostatic pressure-driven application (40 to 50 cm H2O)
through polyethylene tubes (0.5 mm inner diameter).
Chemicals
Hepes was purchased from Dojin Co. Ltd., Kumamoto, Japan. Collagenase was from Wako Pure Chemicals, Osaka, Japan. Other chemicals and reagents, including pL-Arg (average molecular weight [mw] = 12,100) and pL-Lys (average mw = 26,500), were all purchased from Sigma Chemical Co., St. Louis, MO.
Statistical Analysis
The data are expressed as means ± standard error of the mean. For mean comparisons, two-tailed paired or unpaired Student's t test was used. A P < 0.05 was considered statistically significant. n denotes the number of experiments on different cells.
| |
Results |
|---|
|
|
|---|
Effects of Polycations on the Whole-Cell Membrane Potential
The membrane potential (Mp) was recorded with a whole-cell current-clamp configuration. The mean resting Mp
was
39.7 ± 1.1 mV (n = 54). Both pL-Arg and pL-Lys
depolarized the Mp rapidly, causing it reach a plateau
level within a few seconds after the introduction of either
polycation. The depolarizing effect persisted as long as the
polycation was present (up to 15 min in the present study)
and the effect was rapidly reversible with removal of the agent. As the membrane depolarized, the Mp often exhibited transient, spiky, sporadic hyperpolarizations (Figure
1A). As shown in Figure 1B, both of the agents significantly depolarized the membrane in a concentration-
dependent fashion with a similar potency. That is, in the
presence of pL-Lys, the Mp was depolarized from a baseline of
40.1 ± 1.5 to
25.1 ± 5.0 mV (P < 0.05; n = 9) with 10 µg/ml and from
43.6 ± 3.9 to
25.1 ± 4.5 mV (P < 0.05; n = 6) with 100 µg/ml. Similarly, pL-Arg depolarized
it from
39.3 ± 1.7 to
25.6 ± 6.1 mV (P < 0.05; n = 11)
with 10 µg/ml and from
38.0 ± 3.3 to
21.0 ± 4.3 mV (P < 0.05; n = 6) with 100 µg/ml.
|
Effects of Polycationic Peptides on Whole-Cell Delayed-Rectifier K+ Current
It has been reported that the resting Mp of tracheal myocytes is determined largely by the delayed rectifier K+ channel (KDR) (18). Therefore, we examined the effects of the polycationic peptides on whole-cell KDR-current. The KDR current was isolated under conditions of very low internal Ca2+ and external high TEA (see MATERIALS AND METHODS). As shown in Figure 2, both pL-Arg and pL-Lys (100 µg each) suppressed the currents significantly with a similar potency. In the presence of the polycations, the peak currents at the respective step voltage were attenuated to around 20% of the pretreatment control values, e.g., from 4.08 ± 1.21 to 0.77 ± 0.25 picoampere/picofarad (pA/pF) at 0 mV Mp and from 10.53 ± 3.00 to 2.73 ± 0.56 at +40 mV (P < 0.05; n = 5) (see Figure 2B).
|
Effects of Polycationic Peptides on Whole-Cell K+ Current
In voltage-clamp whole-cell experiments, we often observed spontaneous transient outward currents (STOCs) (Figure 3). STOCs have been characterized in many systems including vascular (21), intestinal (22), and tracheal (23) smooth-muscle cells, and are believed to represent the activation of Ca2+-dependent K+ currents due to spontaneous and sporadic release of internally sequestered Ca2+. As exemplified in Figure 3A, both pL-Arg (10 µg/ml; n = 6) and pL-Lys (10 µg/ml; n = 4) acutely suppressed the amplitude of STOCs in an immediate manner that was reversible with the withdrawal of the polycations. We analyzed the effects of the polycations on STOC activity by alterations in the frequency and amplitude compared with the pretreatment control values. Both parameters were significantly suppressed in the presence of either agent, i.e., the frequency was suppressed to 57.7 ± 13.6% of the preceding control values without the polycations (P < 0.01; n = 7) and the amplitude was decreased to 77.1 ± 9.8% of the controls (P < 0.05; n = 7) (Figure 3B).
|
Effects of Polycationic Peptides on Large Conductance K+ Channels on Excised Outside-Out Patches
Because STOCs are believed to be carried by K+ effluxed
through large-conductance Ca2+-sensitive K+ channels
(maxi-K channels) (21) and because it was the maxi-K channel that was the most frequently and easily identifiable channel on excised patch membranes (18, 24), we examined whether the cationic polypeptides affect this type
of channel on outside-out membrane patches in a quasi-physiologic electrolyte environment. A representative recording of maxi-K channel activity is shown in Figure 4A.
This was identified as a maxi-K channel because (1) the
slope conductance at 0 mV Mp was about 130 pS; (2) the estimated reversal potential was about
80 mV, which
was close to the equilibrium for K+ under the present electrolyte compositions (Figure 4B); and (3) the channel activity was totally abolished by TEA (10 mM) and charybdotoxin (100 nM) but was insensitive to 4-aminopyridine (4AP) (2 mM) (data not shown). As shown in Figure 4A,
the introduction of either pL-Arg or pL-Lys attenuated
both the nPo and the amplitude of the unitary current of
the channel. The current-voltage (I-V) relationship of the
channel demonstrated that the channel had a slope conductance of 124.0 ± 7.9 pS at 0 mV Mp in the standard extra- and intracellular solutions (n = 18), which was decreased to 66.6 ± 3.9 pS in the presence of the cationic
polypeptides (n = 14; about 54% of control, P < 0.0001).
The nPo was also decreased significantly to 21.8 ± 20.3%
(P < 0.05; n = 6) and 26.5 ± 9.5% (P < 0.005; n = 4) of
the pretreatment control values by pL-Arg and pL-Lys, respectively (Figure 4C). These suppressing effects of pL-Arg on nPo and amplitude were abolished in the presence of heparin, a negatively charged macromolecule. Heparin
has been reported to neutralize the positive charge of
polycations and to abolish their effects (8, 10, 17). Using
5 U/ml of heparin, we tested the outside-out maxi-K+
channel activity. Heparin alone exhibited no effect on the
activities of the channel. However, the nPo and amplitude
attenuated by pL-Arg (10 µg/ml) regained their preceding
baseline values with the additional heparin (n = 3).
|
Effects of Polycationic Peptides on Whole-Cell Ca2+ Current
In a recent report, synthetic polycationic peptides were found to directly mobilize Ca2+ and to increase the basal tension in bovine tracheal smooth muscle (4). To examine the possibility of polycations acting directly on Ca2+ channels to cause Ca2+ influx, we investigated the effects of the polycations on the depolarization-activated whole-cell Ca2+ current. The methods of identifying Ca2+ current largely conformed to a previous publication (25), as described in MATERIALS AND METHODS. As shown in Figure 5A, we recognized inward currents stimulated by the membrane depolarization that were completely abolished in the presence of nifedipine, an inhibitor of L-type Ca2+ channels. The electric properties of the present inward currents, including the I-V relationship (Figure 5B), were qualitatively identical to the Ca2+-channel currents reported in canine tracheal myocytes (25, 26) and others (18). The polycations were without effect on the Ca2+-channel current in bovine tracheal myocytes (Figure 5B).
|
| |
Discussion |
|---|
|
|
|---|
The contraction/relaxation in airway smooth muscle is regulated by complex pharmaco- and electromechanical processes. In the present study we investigated the effects of
synthetic polycations on the electrophysiologic aspects of
single tracheal myocytes. We chose the synthetic polycationic peptides pL-Arg and pL-Lys as model cationic proteins not only because they share a similar molecular
weight and charge density with MBP, but also because they reportedly mimicked the biologic actions of endogenous cationic proteins including MBP, PF4, and cathepsin
G (4, 8, 10, 17). The magnitude of the membrane depolarization induced by the synthetic polycations in the present
study was from about
40 to
20 mV. A sustained depolarization around
20 mV has been observed to be sufficient for a sustained rise in [Ca2+]i and resulting smooth-muscle contraction (18, 27). The Mp of bronchial smooth
muscle is one of the major determinants of the bronchial
tone and is regulated mainly by K+ channels (18, 19, 24).
The opening of K+ channels hyperpolarizes and the closing depolarizes the membrane, which correlate to a certain
extent with the relaxation and contraction of bronchial
smooth muscle, respectively (28). Several types of K+
channels have been identified in airway myocytes, e.g., a
large-conductance, voltage-dependent, Ca2+-activated K+
channel (referred to as a maxi-K, BK, or KCa channel) (18, 23, 24, 29, 30); a voltage-dependent, delayed-rectifying K+
channel (KDR channel) (18, 19, 20); and an ATP-sensitive K+ channel (KATP channel) (31). Although the physiologic
roles of the respective K+ channels in controlling smooth-muscle tone have not yet been unequivocally established,
it appears likely that the resting membrane potential is determined largely by KDR channels (18). It has been reported that the resting Mp of airway myocytes from ferret
trachea (20) and human airway (19) was depolarized in the
presence of 4AP, an inhibitor specific to KDR channels, whereas charybdotoxin and glybenclamide, inhibitors specific to maxi-K channels and KATP channels, respectively, were
without effect. In the present study, synthetic polycations
mimicked the KDR inhibitor and depolarized the resting Mp
of bovine tracheal myocytes in a concentration-dependent
fashion (Figure 1). This suggests that the synthetic polycations suppressed the activity of KDR channels in bovine tracheal myocytes, thereby causing membrane depolarization.
This idea was confirmed by the voltage-clamp experiments at very low intracellular Ca2+ (Figure 2). The slow-activating and time-dependent inactivating kinetics and the voltage dependency of the current were quite similar to those
of the reported KDR current in airway myocytes (18).
These currents were significantly attenuated in the presence of the synthetic polycations.
Wylam and coworkers found that both MBP and model polycations induced an acute transient increase and a subsequent sustained elevation in basal [Ca2+]i in cultured myocytes (4). There seems to be a general agreement concerning cellular Ca2+ mobilization that the initial transient increase in [Ca2+]i is likely to have an intracellular origin and the subsequent sustained one comes from outside the cell. In the present electrophysiology we showed the latter pathway alone, that is, polycationic proteins can activate the Ca2+ entry via membrane depolarization, showing only a monophasic pattern, in tracheal myocytes. Of course, other mechanisms, e.g., a pharmacomechanical one, along with the present electromechanical pathway, can underlie the direct contractile action of polycations. However, we could not detect an electrophysiologic event corresponding to the initial transient increase in cellular Ca2+ observed in cultured myocytes (4). Thus, we found one aspect of the complex process by which polycationic peptides activate smooth-muscle cells. Another point that should be discussed concerns the apparent difference between the time courses in the reported tension development and in the present membrane depolarization. The present membrane depolarization showed an acute onset with the introduction of the polycations and was rapidly reversible, but isometric tension began to increase after 5 min of polycation treatment and was apparently irreversible by three rinses (4). We have no appropriate explanations for this difference, however differences in the tissue preparations might be considered. We used an isolated single tracheal myocyte, whereas 2-mm-wide by 10-mm-long tracheal wall smooth-muscle strips were used in Wylam's tension experiment. It may require a certain interval for 10 kD or more of the charged peptides to penetrate or to be washed out from the macroscopic mass of smooth muscle.
As is discernible in the Mp recording shown in Figure 1A, frequent transient hyperpolarizations were observed as depolarization progressed. Presumably, this is a reciprocal expression of the sporadic activation of Ca2+-activated K+ channels, i.e., STOCs. STOCs have been well characterized in smooth-muscle cells, including vascular (21), intestinal (22), and tracheal (23) myocytes, and are known to be carried by K+ via maxi-K channels (21). STOCs are also known to be activated by membrane depolarization (21), which seemed to be the cause of the appearance of the present spontaneous hyperpolarizations. Activations of maxi-K+ channels by adrenergic agonists relax airway smooth muscle, probably by sensitizing the channels to Ca2+ via phosphorylating the channel protein (29, 30). Thus, maxi-K channels and STOCs have been considered important regulators of smooth-muscle relaxation. In the present study, the synthetic polycations suppressed the STOCs recorded with the whole-cell configuration (Figure 3). This was most probably due to the direct effect of the polycations on maxi-K channels, as supported by the excised patch experiments. That is, maxi-K channels were inactivated in the presence of polycations both in the conductance and nPos (Figure 4). It is possible that the decreased single-channel amplitude results from a decrease in the channel open time, producing an apparent decrease in conductance. To avoid this, we employed a 5-kHz bandwidth for the channel recording, differing from that in the whole-cell experiments (see MATERIALS AND METHODS). We found that the conductance of the maxi-K channel was decreased to about 60% of the control value in the presence of the polycations. Interestingly, this mimicked one of the "subconductance states" of the maxi-K channel reported in canine trachealis (32), which was 63% of the full conductance. Although it is beyond the scope of the present investigation, a detailed kinetic study may give some insights into the mode of action of polycations on the channel gating. However, the possibility still remains that the polycations affect the channel gating indirectly, e.g., due to arachidonic acid metabolites generated from lipids in the excised patch membrane.
When considering the physiologic significance of the present study, the results obtained from the Ca2+-current experiment seem to be important because the ineffectiveness of synthetic polycations on Ca2+ currents supports the notion of depolarization-induced Ca2+ influx. This also indicates that the action of polycations has some specificity that depends on the channel species. In some cells, small outward currents were observed after the abolition of the inward Ca2+ current by nifedipine (see Figure 5A, lower panel). Although small in amplitude, the current kinetics were reminiscent of the delayed rectifier K+ currents shown in Figure 2. We thought that, in spite of the complete replacement of K+ in the experimental solutions, potassium ions residual in the cell interior that escaped dialysis might be responsible for the small currents. A similar observation has been reported with regard to the rates of diffusional exchange, and this can occur especially in larger cells (33).
In the present study we demonstrated that the polycationic peptides depolarized the membrane and inhibited the maxi-K channel in bovine tracheal myocytes directly without affecting the Ca2+-channel current. The present investigation uncovered for the first time the mechanism underlying the direct contractile and Ca2+-mobilizing effects of polycations on airway smooth muscle (4, 8). The polycationic proteins released from a variety of cells, including eosinophils, neutrophils, and platelet and airway epithelial cells, may play some part in the pathogenesis of AHR in chronic inflammatory airway diseases.
| |
Footnotes |
|---|
Abbreviations: airway hyperresponsiveness, AHR; adenosine triphosphate,
ATP; cellular Ca2+ concentration, [Ca2+]i; ethyl glycol-bis(
-aminoethyl
ether)-N,N,N',N',-tetraacetic acid, EGTA; N-2-hydroxyethylpiperazine-
N'-2-ethane sulfonic acid, Hepes; large-conductance Ca2+-dependent K+
channel, maxi-K channel; major basic protein, MBP; membrane potential,
Mp; open-state probability(ies), nPo; poly-L-arginine, pL-Arg; poly-L-lysine,
pL-Lys; spontaneous transient outward current, STOC; tetraethyl ammonium, TEA.
(Received in original form June 21, 1999 and in revised form October 22, 1999).
Acknowledgments: The authors gratefully acknowledge Mr. Brent Bell for reading the manuscript. This work was supported by Grant-in-Aid for Scientific Research (No. 09670593) from The Ministry of Education, Science, Sports and Culture, Japan.
| |
References |
|---|
|
|
|---|
1. Boushey, H. A., M. J. Holtzman, J. R. Sheller, and J. A. Nadel. 1980. Bronchial hyperreactivity. Am. Rev. Respir. Dis. 121: 389-413 [Medline].
2. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323: 1033-1039 [Abstract].
3. Ackerman, S. J., D. A. Loegering, P. Venge, I. Olsson, J. B. Harley, A. S. Fauci, and G. J. Gleich. 1983. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J. Immunol. 131: 2977-2982 [Abstract].
4. Wylam, M. E., N. Gungor, R. W. Mitchell, and J. G. Umans. 1998. Eosinophils, major basic protein, and polycationic peptides augment bovine airway myocyte Ca2+ mobilization. Am. J. Physiol. 274(Lung Cell. Mol. Physiol. 18):L997-L1005.
5. Flavahan, N. A., N. R. Slifman, G. J. Gleich, and P. M. Vanhoutte. 1988. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am. Rev. Respir. Dis. 138: 685-688 [Medline].
6. Coyle, A. J., S. J. Ackerman, R. Burch, D. Proud, and C. G. Irvin. 1995. Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J. Clin. Invest. 95: 1735-1740 .
7. Strek, M. E., F. S. Williams, G. J. Gleich, A. R. Leff, and S. R. White. 1995. Mechanisms of smooth muscle contraction elicited by cationic proteins in guinea pig trachealis. Am. J. Physiol. 270(Lung Cell. Mol. Physol. 14): L133-L140.
8. Spina, D., and R. G. Goldie. 1994. Contractile properties of synthetic cationic polypeptides in guinea-pig isolated trachea. Br. J. Pharmacol. 111: 29-34 [Medline].
9. McFaddin, E. R., Jr. 1991. Airway responsivity and chronic obstructive lung disease. In Chronic Obstructive Pulmonary Disease. N. S. Cherniack, editor. Saunders, Philadelphia. 90-96.
10. Coyle, A. J., S. J. Ackerman, and C. G. Irvin. 1993. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am. Rev. Respir. Dis. 147: 896-900 [Medline].
11. Priè, S., D. M. Conroy, G. J. Gleich, and P. Sirois. 1996. Eosinophils and neutrophils modify arachidonic acid-induced relaxation of guinea-pig trachea. Eur. J. Pharmacol. 317: 343-351 [Medline].
12. Annesi, I., F. Kauffmann, M. P. Oryszczyn, F. Neukirch, E. Orvoen-Frija, and J. Lellouch. 1988. Leukocyte count and bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 82: 1006-1011 [Medline].
13. Spitznagel, J. K.. 1990. Antibiotic proteins of human neutrophils. J. Clin. Invest. 86: 1381-1386 .
14. Chang, S.-W., and N. Voelkel. 1989. Charge-related lung microvascular injury. Am. Rev. Respir. Dis. 139: 534-545 [Medline].
15.
Diamond, G.,
M. Zasloff,
H. Eck,
M. Brasseur,
W. L. Maloy, and
C. L. Bevins.
1991.
Tracheal antimicrobial peptide, a cysteine-rich peptide from
mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.
Proc. Natl. Acad. Sci. USA
88:
3952-3956
16. Young, J. D.-E., C. G. B. Peterson, P. Venge, and Z. A. Cohn. 1986. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321: 613-616 [Medline].
17. Coyle, A. J., D. Uchida, S. I. Ackerman, W. Mitzner, and C. G. Irvin. 1994. Role of cationic proteins in the airway: hyperresponsiveness due to airway inflammation. Am. J. Respir. Crit. Care Med. 150: S63-S71 .
18. Kotlikoff, M. I. 1989. Ion channels in airway smooth muscle. In Airway Smooth Muscle in Health and Disease. R. F. Coburn, editor. Plenum, New York. 169-182.
19.
Adda, S.,
B. K. Fleischmann,
B. D. Freedman,
M.-F. Yu,
D. W. P. Hay, and
M. I. Kotlikoff.
1996.
Expression and function of voltage-dependent potassium channel genes in human airway smooth muscle.
J. Biol. Chem.
271:
13239-13243
20.
Fleischmann, B. K.,
R. J. Washabau, and
M. I. Kotlikoff.
1992.
Control of
resting membrane potential by delayed rectifier potassium currents in ferret airway smooth muscle cells.
J. Physiol. (Lond.)
469:
625-638
21.
Ganitkevich, V., and
G. Isenberg.
1990.
Isolated guinea pig coronary smooth
muscle cells. Acetylcholine induces hyperpolarization due to sarcoplasmic
reticulum calcium release activating potassium channels.
Circ. Res.
67:
525-528
22.
Bolton, T. B., and
S. P. Lim.
1989.
Properties of calcium stores and transient
outward currents in single smooth muscle cells of rabbit intestine.
J. Physiol. (Lond.)
409:
385-401
23.
Saunders, H.-M. H., and
J. M. Farley.
1991.
Spontaneous transient outward
currents and Ca2+-activated K+ channels in swine tracheal smooth muscle
cells.
J. Pharmacol. Exp. Ther.
257:
1114-1120
24.
McCann, J. D., and
M. J. Welsh.
1986.
Voltage-gated Ca-activated K channels in isolated canine airway smooth muscle cells.
J. Physiol. (Lond.)
372:
113-127
25. Kotlikoff, M. I. 1988. Calcium currents in isolated canine airway smooth muscle cells. Am. J. Physiol. 254(Cell Physiol. 23):C793-C801.
26. Green, K. A., R. C. Small, and R. W. Foster. 1993. The properties of voltage-operated Ca2+-channels in bovine isolated trachealis cells. Pulm. Pharmacol. 6: 49-62 [Medline].
27. Fleischmann, B. K., R. K. Murray, and M. I. Kotlikoff. 1994. Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. Proc. Natl. Acad. Sci. USA 91: 1194-1198 .
28.
Farley, J. M., and
P. R. Miles.
1977.
Role of depolarization in acetylcholine-induced contractions of dog trachealis muscle.
J. Pharmacol. Exp. Ther.
201:
199-205
29. Kume, H., A. Takai, H. Tokuno, and T. Tomita. 1989. Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation. Nature 341: 152-154 [Medline].
30.
Nara, M.,
P. D. K. Dhulipala,
Y.-X. Wang, and
M. I. Kotlikoff.
1998.
Reconstitution of
-adrenergic modulation of large conductance, calcium-activated potassium (Maxi-K) channel in Xenopus oocytes. Identification of
the cAMP-dependent protein kinase phosphorylation site.
J. Biol. Chem.
273:
14920-14924
31. Black, J. L., C. L. Armour, P. R. Johnson, L. A. Alouan, and P. J. Barnes. 1990. The action of a potassium channel activator, BRL 38227 (lemakalim), on human airway smooth muscle. Am. Rev. Respir. Dis. 142: 1384-1389 [Medline].
32. Stockbridge, L. L., A. A. French, and S. F. P. Man. 1991. Subconductance states in calcium-activated potassium channels from canine airway smooth muscle. Biochim. Biophys. Acta 1064: 212-218 [Medline].
33. Pusch, M., and E. Neher. 1988. Rates of diffusional exchange between small cells and a measuring patch pipette. Pflugers Arch. 411: 204-211 [Medline].
This article has been cited by other articles:
![]() |
Q. Gu, M. E. Wiggers, G. J. Gleich, and L.-Y. Lee Sensitization of isolated rat vagal pulmonary sensory neurons by eosinophil-derived cationic proteins Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L544 - L552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sausbier, X.-B. Zhou, C. Beier, U. Sausbier, D. Wolpers, S. Maget, C. Martin, A. Dietrich, A.-R. Ressmeyer, H. Renz, et al. Reduced rather than enhanced cholinergic airway constriction in mice with ablation of the large conductance Ca2+-activated K+ channel FASEB J, March 1, 2007; 21(3): 812 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kume, T. Ishikawa, T. Oguma, S. Ito, K. Shimokata, and M. I. Kotlikoff Involvement of Ca2+ Mobilization in Tachyphylaxis to {beta}-Adrenergic Receptors in Trachealis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mark Madison and C. M. Schramm Cationic Proteins and Bronchial Hyperresponsiveness Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 513 - 516. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |